Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients?

Version 1 : Received: 9 September 2022 / Approved: 16 September 2022 / Online: 16 September 2022 (02:00:02 CEST)

How to cite: Salvadori, M. What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients? . Preprints 2022, 2022090233 (doi: 10.20944/preprints202209.0233.v1). Salvadori, M. What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients? . Preprints 2022, 2022090233 (doi: 10.20944/preprints202209.0233.v1).

Abstract

Abstract Kidney transplant recipients, because of a weak immune response due to the assumption of immunosuppressant are exposed to the risk of COVID-19 infection. This fact realize the problem on how to treat the severe infection without carrying the risk of acute rejection due to the reduction of the immunosuppressive drugs. The best are the prophylactic measures to be taken before transplantation as vaccination. If the patient is already transplanted, three measures may be undertaken: Vaccination, use of monoclonal antibodies, use of therapeutic antiviral small molecules. Concerning vaccination is still debated which one is the best and how many doses should be given. The surge of new virus variant is the major problem and invites to find new active vaccines. In addition, not all the transplanted patients develop antibodies. The other measure is the use of monoclonal antibodies. They may be used as prophylaxis or in the early stage of the disease. Finally, the antiviral small molecules may be used again as prophylaxis or treatment. Their major drawback are the interference with the immunosuppressive drugs and the fact that some of them cannot be administered to patients with low eGFR.

Keywords

COVID-19 prophylaxis; COVID-19 treatment; Kidney transplantation; Vaccination; Monoclonal antibodies; Small antivirus molecules

Subject

MEDICINE & PHARMACOLOGY, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.